Health Care: Drugs

Allergan Inc (AGN: NYSE)

$222.39 0.03 | 0.01%
01/29/15 - 04:01 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 988.70M 1.10B 938.10M 4.90M
Operating Gains/Losses 417.40M 5.70M 5.90M 15.50M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -139.60M -34.30M -105.60M -71.40M
(Increase) Decrease in Inventories -26.90M -7.30M -24.00M -5.60M
(Increase) Decrease In Other Current Assets -800.00K -16.00M -33.10M -11.30M
(Decrease) Increase In Payables 37.40M 32.70M -19.30M 8.60M
(Decrease) Increase In Other Current Liabilities 175.10M 125.50M 19.30M 11.70M
(Increase) Decrease In Other Working Capital 1.60M 70.80M 200.00K 0.00
Other Non-Cash Items 191.90M 157.80M 107.50M 476.40M
Net Cash From Continuing Operations 1.70B 1.60B 1.08B 463.90M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.70B 1.60B 1.08B 463.90M
Sale of Property, Plant & Equipment 500.00K 1.80M 1.20M 400.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 683.20M 784.60M 1.14B 75.00M
Purchases of Property, Plant & Equipment -184.00M -161.30M -130.10M -157.00M
Acquisitions -849.40M -349.20M -101.40M -69.80M
Purchases of Short-Term Investments -1.03B -865.20M -571.10M -824.10M
Other Cash from Investing Activities 0.00 0.00 0.00 -1.70M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.38B -589.30M 340.80M -977.20M
Issuance of Debt 598.50M 0.00 0.00 648.00M
Cash Used for Financing Activities
Issuance of Capital Stock 179.30M 246.40M 264.00M 234.00M
Repayment of Long-Term Debt 0.00 0.00 -808.90M 0.00
Repurchase of Capital Stock -650.70M -909.00M -461.70M -286.00M
Payment of Cash Dividends -77.40M -60.40M -61.10M -60.60M
Other Financing Charges, Net -21.50M 5.50M 65.40M 27.60M
Net Cash From Financing Activities 28.20M -717.50M -1.00B 563.00M
Effect of Exchange Rate Changes -4.00M 2.60M -5.50M -5.60M
Net Change in Cash & Cash Equivalents 344.30M 295.70M 414.90M 44.10M

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases

Partner Headlines for AGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter